[1]
Boucenna, A., Hirech, A., Larbi, R.M. and Satta, D. 2024. Impact of CYP2D6 Polymorphisms in Predicting Occurrence of Adverse Effect to Tamoxifen and Developing Recurrence in ER+ Breast Cancer Patients. Archives of Breast Cancer. 11, 4 (Oct. 2024). DOI:https://doi.org/10.32768/abc.2024114392-399.